US 2019/0314273 A1Published application

Pharmaceutical hydrocortisone solution for an injection device

AssigneeCrossject

InventorsPauline BARDONNAUD, Frédérique FLORES-IVANEZ

Life of this patent

Estimating the term…

Abstract

A pharmaceutical hydrocortisone solution including at least hydrocortisone or a pharmaceutically-acceptable salt thereof, rongalite, disodium EDTA, and a solvent. Also relates to its use in the treatment of acute adrenal insufficiency and asthma. Also relates to an injection kit including an injection device and this pharmaceutical solution

Claims13

Dependent claims

A pharmaceutical hydrocortisone solution which comprises at least:

hydrocortisone or a pharmaceutically-acceptable salt thereof;
rongalite;
disodium ethylenediaminetetraacetic acid (disodium EDTA);
a solvent.

1 more element

Dependencies are inferred from the claim text.

Facts

Application: 16/343,163Filed 25 Oct 2017
Priority: FR 16/6039326 Oct 2016
Published: 17 Oct 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 31/10
Sulfur, selenium, or tellurium compounds, e.g. thiols: sulfides; Sulfoxides; Sulfones
A61K 31/573
Substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone: substituted in position 21, e.g. cortisone,…
A61K 47/02
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…:…

Family

US 10,456,355 B1Related patent
US 2019/0314273 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results